PSA DENSITY IS A STRONGER PROGNOSTIC FACTOR THAN PSA IN LOCALLY ADVANCED PROSTATE CANCER: A MULTI-CENTER EXPERIENCE

被引：0
|
作者：
Chao-Yu, H.
Martin, S.
Paolo, G.
Alberto, B.
Giansilvio, M.
Bertrand, T.
Hein, V
Steven, J.
机构：
来源：
INTERNATIONAL JOURNAL OF UROLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：357 / 357
页数：1
相关论文
共 50 条
  • [21] Is PSA kinetics during radiation therapy a prognostic indicator for prostate cancer patients? A preliminary experience
    Stefanacci, M
    Di Lieto, M
    Vezzani, E
    Orlandini, L
    Chiavacci, A
    TUMORI, 2001, 87 (04) : S136 - S137
  • [22] Clinical Outcomes in a Locally Advanced Non-metastatic Prostate Cancer Presenting with Low PSA at Diagnosis
    Haris, M.
    Maitre, P.
    Logue, J.
    Wylie, J.
    Hoskin, P.
    Choudhury, A.
    CLINICAL ONCOLOGY, 2024, 36 (01) : E80 - E81
  • [23] Expression of P21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy
    Lacombe, L
    Maillette, A
    Meyer, F
    Veilleux, C
    Moore, L
    Fradet, Y
    INTERNATIONAL JOURNAL OF CANCER, 2001, 95 (03) : 135 - 139
  • [24] End of Treatment PSA as a Novel Prognostic Factor in Patients Undergoing Definitive Radiation for Prostate Cancer
    Narang, A.
    Ram, A. N.
    Robertson, S. P.
    He, P.
    Griffith, E.
    Singh, H.
    DeWeese, T.
    Honig, S.
    McNutt, T. R.
    Song, D.
    Tran, P. T.
    DeWeese, T. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S454 - S455
  • [25] The nadir PSA level is a significant prognostic factor in Taiwanese men with bone metastatic prostate cancer
    Wang, Tsung-Wei
    Ou, Yen-Chuan
    Yang, Chi-Rei
    INTERNATIONAL JOURNAL OF UROLOGY, 2010, 17 : A291 - A292
  • [26] DECREASE IN ULTRASENSITIVE PSA AFTER RADICAL PROSTATECTOMY AS THE PROGNOSTIC FACTOR OF BIOCHEMICAL RECURRENCE OF PROSTATE CANCER
    Vesely, S.
    Jarolim, L.
    Kawaciuk, I.
    Hanek, P.
    Schmidt, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 294 - 294
  • [27] Prognostic value of PSA nadir ≤4 ng/mL within 4 months of high-dose radiotherapy for locally advanced prostate cancer
    Nickers, Philippe
    Albert, Adelin
    Waltregny, David
    Deneufbourg, Jean-Marie
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (01): : 73 - 77
  • [28] DO PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR LOCALLY ADVANCED PROSTATE CANCER AND PSA >50 ng/ml HAVE A WORSE PROGNOSIS THAN PATIENTS WITH PSA>20 ng/ml?
    Marchioro, Giansilvio
    Maso, Gloria
    Vidali, Matteo
    Volpe, Alessandro
    Tarabuzzi, Roberto
    Zaramella, Stefano
    Zacchero, Monica
    De Lorenzis, Elisa
    Crivellaro, Simone
    Frea, Bruno
    Terrone, Carlo
    ANTICANCER RESEARCH, 2010, 30 (04) : 1435 - 1435
  • [29] DO PATIENTS TREATED WITH RADICAL PROSTATECTOMY FOR LOCALLY ADVANCED PROSTATE CANCER AND PSA >50 MG/ML HAVE A WORSE PROGNOSIS THAN PATIENTS WITH PSA>20 MG/ML?
    Marchioro, G.
    Volpe, A.
    Vidali, M.
    Tarabuzzi, R.
    Zaramella, S.
    Zacchero, M.
    Varvello, F.
    De Lorenzis, E.
    Frea, B.
    Terrone, C.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 217 - 218
  • [30] Expression of P21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy.
    Maillette, A
    Moore, L
    Lacombe, L
    Fradet, Y
    JOURNAL OF UROLOGY, 1998, 159 (05): : 181 - 181
12345